Capricor Therapeutics Inc
NASDAQ:CAPR
During the last 3 months Capricor Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 1% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/capr/vs/indx/gspc">open performance analysis).
The last transaction was made on
Sep 20, 2024
by
Nippon Shinyaku Co Ltd
, who
bought
15m USD
worth of
CAPR shares.
During the last 3 months Capricor Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 1% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/capr/vs/indx/gspc">open performance analysis).
The last transaction was made on
Sep 20, 2024
by
Nippon Shinyaku Co Ltd
, who
bought
15m USD
worth of
CAPR shares.
Capricor Therapeutics Inc
Glance View
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. The company is headquartered in Beverly Hills, California and currently employs 48 full-time employees. The company went IPO on 2002-06-04. The firm consists of cell therapy program, including CAP-1002 for Duchenne Muscular Dystrophy program and CAP-1002 with CAP-1002 for coronavirus (COVID-19). The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is in clinical development for treating Duchenne muscular dystrophy and the cytokine storm associated with COVID-19. Capricor is also developing its exosome technology therapeutic platform. The firm is focused on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA) as well as proteins, to treat or prevent a range of diseases. CAP-1002 cell therapy programs initiated Pivotal Phase III, HOPE-3.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.